Callos Andrew bought CYTK

December 5, 2025 · Form 4 insider transaction

Callos Andrew bought 15,858 shares of Cytokinetics, Incorporated at $37.63 per share, a transaction worth $596.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.